Clinical Trials List
2008-10-15 - 2012-12-31
Phase IV
Terminated2
ICD-10N00.0
Acute nephritic syndrome with minor glomerular abnormality
ICD-10N00.1
Acute nephritic syndrome with focal and segmental glomerular lesions
ICD-10N00.2
Acute nephritic syndrome with diffuse membranous glomerulonephritis
ICD-10N00.3
Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis
ICD-10N00.4
Acute nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis
ICD-10N00.5
Acute nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
ICD-10N00.6
Acute nephritic syndrome with dense deposit disease
ICD-10N00.7
Acute nephritic syndrome with diffuse crescentic glomerulonephritis
ICD-9580.0
Acute glomerulonephritis, with lesion of proliferative glomerulonephritis
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- 高芷華 Division of Nephrology
- Jenq-Wen Huang Division of Nephrology
- - - Division of Nephrology
- VIN-CENT Wu Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 黃惠勇 Division of Nephrology
- Wen-Chin Lee Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
2800 participants
